{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Deshmukh R"],"funding":["Prince Sattam Bin Abdulaziz University"],"pagination":["297"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10976144"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(3)"],"pubmed_abstract":["Prostate cancer is one of the most life-threatening disorders that occur in males. It has now become the third most common disease all over the world, and emerging cases and spiking mortality rates are becoming more challenging day by day. Several approaches have been used to treat prostate cancer, including surgery, radiation therapy, chemotherapy, etc. These are painful and invasive ways of treatment. Primarily, chemotherapy has been associated with numerous drawbacks restricting its further application. The majority of prostate cancers have the potential to become castration-resistant. Prostate cancer cells exhibit resistance to chemotherapy, resistance to radiation, ADT (androgen-deprivation therapy) resistance, and immune stiffness as a result of activating tumor-promoting signaling p"],"journal":["Pharmaceutics"],"pubmed_title":["Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications."],"pmcid":["PMC10976144"],"funding_grant_id":["PSAU/2024/R1445"],"pubmed_authors":["Prajapati BG","Garg A","Elossaily GM","Ansari MN","Harwansh RK","Deshmukh R","Ali N","Singh S","Singh V","Agrawal R"],"additional_accession":[]},"is_claimable":false,"name":"Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications.","description":"Prostate cancer is one of the most life-threatening disorders that occur in males. It has now become the third most common disease all over the world, and emerging cases and spiking mortality rates are becoming more challenging day by day. Several approaches have been used to treat prostate cancer, including surgery, radiation therapy, chemotherapy, etc. These are painful and invasive ways of treatment. Primarily, chemotherapy has been associated with numerous drawbacks restricting its further application. The majority of prostate cancers have the potential to become castration-resistant. Prostate cancer cells exhibit resistance to chemotherapy, resistance to radiation, ADT (androgen-deprivation therapy) resistance, and immune stiffness as a result of activating tumor-promoting signaling p","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Feb","modification":"2025-04-21T21:26:36.815Z","creation":"2025-04-05T18:25:04.02Z"},"accession":"S-EPMC10976144","cross_references":{"pubmed":["38543191"],"doi":["10.3390/pharmaceutics16030297"]}}